- |||||||||| Enerzair Breezhaler (glycopyrrolate/indacaterol/mometasone) / Novartis, Atectura Breezhaler (indacaterol/mometasone furoate) / Novartis, Merck (MSD)
Enrollment open, Trial primary completion date: IRIDIUM: Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma (clinicaltrials.gov) - Jul 11, 2016 P3, N=3155, Recruiting, Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Apr 2018 --> Oct 2018
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment closed: Flutiform® Compared With Seretide® in the Treatment of COPD (clinicaltrials.gov) - May 17, 2016 P2/3, N=923, Active, not recruiting, Trial primary completion date: May 2016 --> Nov 2016 Recruiting --> Active, not recruiting
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment closed, Trial primary completion date: A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down (clinicaltrials.gov) - Oct 23, 2015 P4, N=224, Active, not recruiting, Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Feb 2016
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Trial primary completion date: Flutiform® Compared With Seretide® in the Treatment of COPD (clinicaltrials.gov) - Sep 28, 2015 P2/3, N=912, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Feb 2016 Trial primary completion date: Nov 2015 --> Mar 2016
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment closed, Trial primary completion date: A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD (clinicaltrials.gov) - Sep 28, 2015 P3, N=1530, Active, not recruiting, Trial primary completion date: Nov 2015 --> Mar 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Apr 2015
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Trial completion, Trial primary completion date: A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers (clinicaltrials.gov) - Sep 28, 2015 P1, N=125, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Apr 2015 Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Oct 2014
- |||||||||| Seebri Breezhaler (glycopyrronium bromide) / Novartis, Vectura, Sosei
Trial initiation date, Trial primary completion date: Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma (clinicaltrials.gov) - Oct 10, 2014 P3, N=1938, Not yet recruiting, Recruiting --> Completed Initiation date: Oct 2014 --> Mar 2015 | Trial primary completion date: Dec 2016 --> May 2017
- |||||||||| Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
Enrollment closed: Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years. (clinicaltrials.gov) - Aug 7, 2014 P2, N=48, Active, not recruiting, Initiation date: Oct 2014 --> Mar 2015 | Trial primary completion date: Dec 2016 --> May 2017 Recruiting --> Active, not recruiting
|